Individualised patient education as supportive lung infection protective technique among patients with acute leukaemia
ISRCTN | ISRCTN36674014 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN36674014 |
Secondary identifying numbers | N/A |
- Submission date
- 09/12/2009
- Registration date
- 18/05/2010
- Last edited
- 16/12/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Tom Møller (Moeller)
Scientific
Scientific
The University Hospitals Centre for Nursing and Care Research UCSF
Rigshospitalet afsnit 7331
Blegdamsvej 9
Copenhagen
2100
Denmark
Phone | +45 (0)3545 7336 |
---|---|
ucsf@ucsf.dk |
Study information
Study design | Randomised controlled clinical intervention study |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Prevention |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Patient education as a complementary non-pharmacological intervention towards hospital acquired lung infection among patients with acute myeloid leukaemia and chemotherapy induced neutropenia |
Study objectives | Individualised structured patient education including clinical procedures for self-measurement of Lung Capacity / Spirometry in combination with Positive Expiratory pressure (PEP) can reduce hospital acquired pneumonia. |
Ethics approval(s) | 1. The Ethical Scientific Committee of Copenhagen Region, 19/06/2008, ref: H-D-2008-025 2. The Danish Data Protection Agency, 22/01/2008, ref: 2008-41-1728 |
Health condition(s) or problem(s) studied | Acute Myeloid Leukaemia (AML); lung infection prevention |
Intervention | Patient education and training to perform self-measurement of lung capacity and mechanical lung traning with Positive Expiratory Pressure (PEP). Patients are included when diagnosed with AML and chemotherapy has commenced. Follow-up period is planned to 3 months after inclusion. The intervention is nurse-led and consists of a structured three level based patient education program given individually to each patient. One program given to both control and intervention group is used for patients training in self-measurement of lung capacity / spirometry twice a day with an electronic pocket monitor, 'PiKo-6'. The time spent by the clinical nurse specialist for initial instruction and education in spirometry varies within 1.5 - 2.5 hours per patient. The second program is provided only to the intervention group and deals with lung training consisting Positive Expiratory Pressure (PEP) using a PEP-flute twice to four times daily depending on values from lung capacity measurement. Time used for initial instruction varies from 30 mins to 1 hour per patient. Both programs describe focus, actions and aims on each of the three levels in the forms. Patients are left in charge when completing the 3 levels based on appraisal from the clinical nurse specialist. Patients are seen as inpatients or outpatients every 7 - 14 days to discuss patients assessments and visualize their lung capacity on an EDB-based monitor. |
Intervention type | Other |
Primary outcome measure | 1. Incidence of X-ray verified lung infiltrates during the 3 month follow up period 2. Forced Expiratory Volume in 1 second (FEV1) as predictive diagnostic tool for pneumonia |
Secondary outcome measures | 1. Quality of Life (QOL) - EORTC-QLQ-C30 2. SF36 short form 3. Hospital Anxiety Depression (HAD) 4. Self-efficacy 5. Coping - Mini Mental Adjustment to Cancer (Mini-MAC) Above outcomes measured at baseline and at 3 month follow up 6. Qualitative findings derived from semi-structured interviews conducted at the end of 3 month follow up. |
Overall study start date | 01/10/2008 |
Completion date | 01/12/2010 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | 100 |
Key inclusion criteria | Patients (>18 years) with Acute Myeloid Leukaemia (AML) and Myelodysplatic Syndrome demanding intensive intravenous chemotherapy and diagnosed at the Copenhagen University Hospitales Rigshospitalet and Herlev Hospital. |
Key exclusion criteria | 1. non-Danish speaking 2. Psychotic patients 3. Patients requiring care in Intensive Care Units (ICUs) |
Date of first enrolment | 01/10/2008 |
Date of final enrolment | 01/12/2010 |
Locations
Countries of recruitment
- Denmark
Study participating centre
The University Hospitals Centre for Nursing and Care Research UCSF
Copenhagen
2100
Denmark
2100
Denmark
Sponsor information
Lundbeck Foundation (Denmark)
Charity
Charity
Universitetshospitalernes Center for Sygepleje- og Omsorgsforskning
Rigshospitalet afsnit 7331
Blegdamsvej 9
2100 København Ø
Copenhagen
2100
Denmark
Phone | +45 (0)35457336 |
---|---|
bente@ucsf.dk | |
Website | http://www.ucsf.dk/ |
https://ror.org/03hz8wd80 |
Funders
Funder type
Charity
Lundbeck Foundation (Denmark) (ref: FP 28/2007)
Private sector organisation / Other non-profit organizations
Private sector organisation / Other non-profit organizations
- Alternative name(s)
- Lundbeckfonden
- Location
- Denmark
Copenhagen University Hospital Rigshospitalet (Denmark)
No information available
Wedell-Wedellsborg Foundation (Denmark) (ref: 381668/933)
No information available
ANCOTRANS (Denmark) - Donation
No information available
Familien Hede Nielsens Foundation (Denmark)
No information available
Ole Wissing's Foundation for Research in Leukaemia (Denmark)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/03/2016 | Yes | No |